NCT04031482 TARGET Registry A Project of the German Network for Intestinal Diseases in Cooperation With Other Corporate Partners Status UNKNOWN Phase N/A
NCT04029649 Beta-1,3/1,6-D-Glucan Ganoderma Lucidum on Ulcerative Colitis Status UNKNOWN Phase PHASE2/PHASE3
NCT04023396 Efficacy and Safety Study of ABX464 as Maintenance Therapy in Patients With Moderate to Severe Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT04018599 Comparison of PK and Tolerability of MSB11022 Administered by AI or PFS Status COMPLETED Phase PHASE1
NCT04006080 Investigation of the Faecal Loss of Vedolizumab and Its Role in Influencing Serum Drug Levels, Outcomes and Response in Ulcerative Colitis Status UNKNOWN Phase PHASE4
NCT04004611 A Study of Mirikizumab (LY3074828) in Children and Teenagers With Ulcerative Colitis (UC) Status COMPLETED Phase PHASE2
NCT04000139 Anthocyanin Rich Extract (ACRE) in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03998488 Examining the Efficacy of Fecal Microbiota Transplantation (FMT) and Dietary Fiber in Patients With Ulcerative Colitis Status COMPLETED Phase PHASE2
NCT03996369 Etrasimod Versus Placebo as Induction Therapy in Moderately to Severely Active Ulcerative Colitis Status COMPLETED Phase PHASE3
NCT03980405 Combination of Diet and 5ASA ( 5-aminosalicylic Acid) for Ulcerative Colitis Status TERMINATED Phase NA
NCT03977480 Phase II Study of Hemay007 in Patients With Active Ulcerative Colitis Status TERMINATED Phase PHASE2
NCT03973437 Development and Validation of a Deep Learning Algorithm to Evaluate Endoscopic Disease Activity of Ulcerative Colitis. Status UNKNOWN Phase NA